You are here

2015

Original articles

Mailly L, Xiao F*, Lupberger J*, Wilson GK, Leboeuf C, Aubert P, Duong FHT, Fofana I, Thumann C, Bandiera S, Lutgehetmann M, Volz T, Davis C, Harris HJ, Girardi E, Chane-Woon-Ming B, Fletcher N, Bartenschlager R, Pessaux P, Meuleman P, Villa P, Pfeffer S, Heim MH, Zeisel MB, Neunlist M, Dandri M, McKeating JA, Robinet E#, Baumert TF#. Clearance of persistent hepatitis C virus infection using a monoclonal antibody specific for tight junction protein claudin-1. Nat. Biotechnol., 2015, 33(5), 549-54.*Authors contributed equally, #Authors contributed equally.

Xiao F*, Fofana I*, Thumann C, Mailly L, Alles R, Robinet E, Meyer N, Schaeffer M, Habersetzer F, Doffoël M, Leyssen P, Neyts J, Zeisel MB, Baumert TF. Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C. Gut, 2015, 64(3), 483-94. *Authors contributed equally.

Tawar RG, Colpitts CC, Timm J, Fehm T, Roggendorf M, Meisel H, Meyer N, Habersetzer F, Cosset FL, Berg T, Zeisel MB, Baumert TF. Acute hepatitis C virus infection induces anti-host cell receptor antibodies with virus-neutralizing properties. Hepatology, 2015, 62(3), 726-36.

Forns X, Charlton M, Denning J, McHutchison JG, Symonds WT, Brainard D, Brand-Sarif T, Chang P, Kivett V, Castells L, Prieto M, Fontana RJ, Baumert TF, Coilly A, Londono MC, Habersetzer F. Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C following liver transplantation. Hepatology, 2015, 61, 1485-94.

Lupberger J, Casanova C, Fischer B, Weiss A, Fofana I, Fontaine N, Fujiwara T, Renaud M, Kopp A, Schuster C, Brino L, Baumert TF, Thoma C. PI4K-beta and MKNK1 are regulators of hepatitis C virus IRES-dependent translation. Sci. Rep., 2015, 5, 13344.

Gerold G, Meissner F, Bruening J, Welsch K, Perin PM, Baumert TF, Vondran FW, Kaderali L, Marcotrigiano J, Khan AG, Mann M, Rice CM, Pietschmann T. Quantitative Proteomics Identifies Serum Response Factor Binding Protein 1 as a Host Factor for Hepatitis C Virus Entry. Cell Rep., 2015, 12(5), 864-78.

Leboeuf C, Roser-Schilder J, Lambotin M, Durand S, Wu T, Fauvelle C, Su B, Bôle-Richard E, Deschamps M, Ferrand C., Tiberghien P, Pessaux P, Baumert TF, Robinet E. Prevention of hepatitis C virus infection by adoptive allogeneic immunotherapy using suicide gene-modified lymphocytes : an in vitro proof-of-concept. Gene Ther., 2015, 22(2), 172-180.

Wu T, Bour G, Durand S, Lindner V, Gosse F, Zona L, Certoux JM, Diana M, Baumert TF, Marescaux J, Mutter D, Pessaux P, Robinet E. Use of a Closed Culture System to Improve the Safety of Lentiviral Vector Production. Hum. Gene Ther. Methods, 2015, 26, 197-210.

Wu T, Leboeuf C, Durand S, Su B, Deschamps M, Zhang X, Ferrand C, Pessaux P, Robinet E. Suicide gene-modified killer cells as an allogeneic alternative to autologous cytokine-induced killer cell immunotherapy of hepatocellular carcinoma. Mol. Med. Reports, 2016, 13, 2645-2654.

Hallet J, Soler L, Diana M, Mutter D, Baumert TF, Habersetzer F, Marescaux J, Pessaux P. Trans-thoracic minimally invasive liver resection guided by augmented reality. J. Am. Coll. Surg., 2015, 220(5), e55-60.

Fletcher NF, Humphreys E, Jennings E, Osburn W, Lissauer S, Wilson GK, Van, ISC, Baumert TF, Balfe P, Afford S, McKeating JA. Hepatitis C virus infection of cholangiocarcinoma cell lines. J. Gen. Virol., 2015, 96(Pt 6), 1380-8.

Calattini S, Fusil F, Mancip J, Dao Thi VL, Granier C, Gadot N, Scoazec JY, Zeisel M, Baumert TF, Lavillette D, Dreux M, Cosset FL. Functional and Biochemical Characterization of HCV Particles Produced in a Humanized Liver Mouse Model. J. Biol. Chem., 2015, 290(38), 23173-87.

Fénéant L, Potel J, François C, Sané F, Douam F, Belouzard S, Calland N, Vausselin T, Rouillé Y, Descamps V, Baumert TF, Duverlie G, Lavillette D, Hober D, Dubuisson J, Wychowski C, Cocquerel L. New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A. J. Virol.; 2015, 89(16), 8346-64.

Diana M, Halvax P, Mertz D, Legner A, Brulé JM, Robinet E, Mutter D, Pessaux P, Marescaux J. Improving Echo-Guided Procedures Using an Ultrasound-CT Image Fusion System. Surg. Innov., 2015, 22, 217-22.

Bonetta AC, Mailly L, Robinet E, Travé G, Masson M, Deryckere F. Artificial microRNAs against the viral E6 protein provoke apoptosis in HPV positive cancer cells. Biochem. Biophys. Res. Commun., 2015, 465(4), 658-64.

Reviews, editorials etc.

Zeisel MB*, Lucifora J*, Mason WS, Sureau C, Beck J, Levrero M, Kann M, Knolle PA, Benkirane M, Durantel D, Michel ML, Autran B, Cosset FL, Strick-Marchand H, Trépo C, Kao JH, Carrat F, Lacombe K, Schinazi RF, Barré-Sinoussi F, Delfraissy JF, Zoulim F. Towards an HBV cure: state-of-the-art and unresolved questions – report of the ANRS workshop on HBV cure. Gut, 2015, 64(8), 1314-26. *the authors contributed equally.

Colpitts CC, Baumert TF. Viral hepatitis: A new HCV cell culture model for the next clinical challenges. Nat. Rev. Gastroenterol. Hepatol., 2015, 12(11), 611-3.

Bandiera S, Pfeffer S, Baumert TF, Zeisel MB. miR-122 – a key factor and therapeutic target in liver disease. J. Hepatol., 2015, 62(2), 448-457.

Colpitts CC, Zeisel MB, Baumert TF. When one receptor closes, another opens: Claudins and the hepatitis C virus E1 glycoprotein. Hepatology, 2015, 62(4), 991-3.

Verrier ER, Wieland S, Baumert TF. Retinoic acid-inducible gene 1 and sensing of hepatitis B virus revisited. Hepatology, 2015, 62(3), 970-2.

Tawar RG, Colpitts CC, Lupberger J, El-Saghire H, Zeisel MB, Baumert TF. Claudins and pathogenesis of viral infection. Semin. Cell Dev. Biol., 2015, 42, 39-46.

Baumert TF, Verrier ER, Nassal M, Chung RT, Zeisel MB. Host-targeting agents for treatment of hepatitis B virus infection. Curr. Opin. Virol., 2015, 14, 41-6.

Zeisel MB, Crouchet E, Baumert TF, Schuster C. Host-targeting agents to prevent and cure hepatitis C virus infection. Viruses, 2015, 7(11), 5659-85.

Colpitts CC, Lupberger J, Doerig C, Baumert TF. Host cell kinases and the hepatitis C virus life cycle. Biochim. Biophys. Acta, 2015, 1854(10PtB), 1657-62.

Hafirassou ML, Meignin C, Baumert T, Schuster C. From fly to man: RACK1, an essential actor of the dependent viral translation of IRES. Med. Sci., 2015, 31(5), 469-72.

Bôle-Richard E, Deschamps M, Ferrand C, Robinet E. Editorial: improving the safety of cell therapy products by suicide gene transfer. Front. Pharmacol., 2015, 6, 174.

Mailly L, Zeisel MB, Baumert TF. Locked outside: cure of chronic hepatitis C using an entry inhibitor. Med. Sci. (Paris), 2015, 31(12), 1075-7.

Colpitts CC, Verrier ER, Baumert TF. Targeting Viral Entry for Treatment of Hepatitis B and C Virus Infections. ACS Infect Dis. 2015, 1(9), 420-7.